Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Hypertension
Description
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. MeSH
Hierarchy View
Subtype Terms (8)
Essential Hypertension
81 drugs (53 approved, 28 experimental)
Hypertension, Pregnancy-Induced
27 drugs (23 approved, 4 experimental)
Hypertension, Pulmonary
156 drugs (100 approved, 56 experimental)
Hypertension, Renal
7 drugs (5 approved, 2 experimental)
Masked Hypertension
7 drugs (4 approved, 3 experimental)
White Coat Hypertension
1 approved drug
Approved Indicated Drugs (98)
Phase 4 Indicated Drugs (115)
Phase 3 Indicated Drugs (61)
Phase 2 Indicated Drugs (81)
Phase 1 Indicated Drugs (76)
Other Experimental Indicated Drugs (110)
Organization Involved with Phase 4 Indications (464)
All India Institute of Medical Sciences
Anhui College of Traditional Chinese Medicine
Aristotle University of Thessaloniki
Association for Innovation and Biomedical Research on Light and Image (AIBILI)
Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology
Atlanta Clinical Research Centers
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
Bill and Melinda Gates Foundation
Boryung Pharmaceutical Company
Cardiology, University and Emergency Hospital, Bucharest, Romania
Caribbean College of Family Physicians
Centre d'Atenció Primaria Bon Pastor
Centre de Salut de Guisona, Guisona, Lleida, Spain
Centro de Salud de Chinchilla, Chinchilla, Albacete, Spain
Centro de Salud de Fuentealbilla, Fuentealbilla, Albacete, Spain
Centro de Salud La Roda, La Roda, Albacete, Spain
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Christian Medical College, Vellore, India
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
COLM Study Research Organization
Competence Network for Congenital Heart Defects
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Daewoong Pharmaceutical Co. LTD.
Daga Memorial Women's Hospital, Nagpur, India
DBYAN Medicine Professional Corporation
Dexcel Pharma Technologies Ltd.
Dr Ivancica Pavlicevic Family Practice Office
Dr. Robert Klempfner Heart Rehabilitation Institute
European Vision Institute Clinical Research Network
Federal University of Rio de Janeiro
Federal University of Rio Grande do Sul
Fundação de Amparo à Pesquisa do Estado de São Paulo
Fundacion Clinica Valle del Lili
Fundación de Investigación en Red en Enfermedades Cardiovasculares
German Federal Ministry of Education and Research
Gottfried Wilhelm Leibniz Universität Hannover
Government Medical College, Nagpur
Hellenic Society of Hypertension
Hospital General Universitario Gregorio Marañon
Hospital Municipal de Badalona
Hospital Universitario Central de Asturias
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Innovative Medical Research of South Florida, Inc
Institut für Pharmakologie und Präventive Medizin
Instituto de Medicina Integral Professor Fernando Figueira
Instituto Mexicano del Seguro Social
INTEGRIS Baptist Medical Center
Italian Society of General Practitioners
Italian Society of Hypertension
Japan Cardiovascular Research Foundation
Japan Seamen's Relief Association Moji Hospital
JSC Scientific Center for Anti-infectious Drugs
Katholieke Universiteit Leuven
Kerckoff clinic, Bad Nauheim, Germany
Krasnogvardeysky District Medical-Physiology Clinic, St. Petesburg, Russia
Kyoto Prefectural University of Medicine
Leadership Sinai Centre for Diabetes
Los Angeles Biomedical Research Institute
Medical University of South Carolina
National Center for Advancing Translational Science (NCATS)
National Center for Research Resources (NCRR)
National Health Service, United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Cardiology, Laranjeiras, Brazil
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of General Medical Sciences (NIGMS)
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Ophthalmic Consultants Centres, Canada
Ophthalmic Consultants of Long Island
People's Hospital of Rongcheng
People's Liberation Army of China
Pokrovskaya Hospital, St. Petesburg, Russia
Postgraduate Institute of Medical Education and Research
PRN Pharmacuetical Research Network, LLC
Rio de Janeiro State University
Russian Academy of Medical Sciences
Samuel Lunenfeld Research Institute
Santa Maria Catholic University
Sao Jose do Rio Preto University
Second Military Medical University
Shanghai Shyndec Pharmaceutical Co.,Ltd.
Shanghai University of Traditional Chinese Medicine
Shenzhen Evergreen Medical Institute
Simcere Pharmaceutical Co., Ltd
Sir Takhtasinhji General Hospital
Smolensk State Medical Academy
Society of Specialists in Heart Failure
Southern Illinois Clinical Research
State University of New York, Brooklyn
State University of New York, Buffalo
St. Elizabeth City Hospital, St. Petersburg, Russia
St.-Josefs-Hospital Cloppenburg
St. Marianna University School of Medicine
St. Petersburg City Hospital #15, St. Petesburg, Russia
St. Petersburg City Hospital #31, St. Petesburg, Russia
St. Petersburg City Hospital #8, St. Petesburg, Russia
St. Petersburg City Outpatient Unit #109, St. Petersburg, Russia
St. Petersburg City Outpatient Unit #25, St. Petesburg, Russia
St. Petersburg Mechnikov State Medical Academy
St. Petersburg Mechnikov State Medical Academy, Russia
Swiss National Science Foundation
Taichung Veterans General Hospital
Technical University of Dresden
The First People's Hospital of Lianyungang
The University of Texas, Dallas
Trinity Hypertension & Metabolic Research Institute
TSH Biopharm Corporation Limited
Universidad Autonoma de Madrid
Universitario de Santiago, Spain
University of British Columbia
University of California, Los Angeles
University of California, San Diego
University of California, San Francisco
University of Campania Luigi Vanvitelli
University of Colorado, Denver
University of Naples Frederico II
University of Roma La Sapienza
University of Southern California
University of Southern Denmark
University of Texas at Houston
University of Western Australia
Virginia Commonwealth University
Virginia Polytechnic Institute and State University
Vita-Salute University of Milano. Italy
Volgograd State Medical University
Wilhelminenspital der Stadt Wien
Yerevan State Medical University, Armenia
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 3 Indications (228)
Adapt Produtos Oftalmológicos Ltda.
Ahn-Gook Pharmaceuticals Co.,Ltd
Alabama Liver & Digestive Specialists Research Center
Alfred E. Tiefenbacher (GmbH & Co. KG)
Assistance Publique - Hôpitaux de Paris
Canadian Institutes of Health Research (CIHR)
Cardiothoracic Surgical Group of Chinese Society of Pediatric Surgery
Case Western Reserve University
Centre Hospitalier Intercommunal Creteil
Centro de Investigación en Alimentación y Desarrollo A.C.
Daewon Pharmaceutical Co., Ltd.
Federal University of Health Science of Porto Alegre
Fondo de Investigacion Sanitaria
Frontier Science and Technology Research Foundation Inc (FS)
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
Hamilton Health Sciences Corporation
Hannover Clinical Trial Center GmbH
Health Sciences Centre Foundation, Manitoba
Hospital General de México Dr. Eduardo Liceaga
Hospital Santa Marcelina, Sao Paulo, Brasil
Hospital Universitari Son Dureta
Institut National de la Santé Et de la Recherche Médicale, France
Interstitial Lung Disease Study Group, Korea
Italian Association of Hospital Pneumologists
Jaeb Center for Health Research
Jiangsu Carefree Pharmaceutical Co., Ltd.
Justus Liebig University Giessen
Laboratorios Sophia S.A de C.V.
Medical Research Council of Canada
Mission Health, North Carolina
National Health and Medical Research Council, Australia
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Child Health and Human Development (NICHD)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Aging (NIA)
Nephron Pharmaceuticals Corporation
Netherlands Organisation for Scientific Research
New England Research Institutes
Nuventra Pharma Sciences, Inc.
Ontario Ginseng Growers Association
Papworth Hospital NHS Foundation Trust
P. Stradina Clinical University Hospital, Latvia
Risk Factor Modification Centre
Shanghai WiseGain Medical Devices Co., Ltd.
St. Luke's-Roosevelt Hospital Center
Taipei Veteran General hospital
Technical University of Munich
The Foundation Institute San Raffaele G. Giglio of Cefalù
The Japanese Society of Hypertension
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
The Stroke Association, United Kingdom
Torrent Pharmaceuticals Limited
Universidad Autonoma de Barcelona
Universidad Complutense de Madrid
University and Emergency Hospital Bucharest, Romania
University Mulitiprofile Hospital for Active Treatment Sv.Georgi, Bulgaria
University of California, Berkeley
University of California, Davis
University of Erlangen-Nuremberg
University of Modena and Reggio Emilia
University of North Carolina at Chapel Hill
University of Texas, Galveston
University Teaching Hospital Hall in Tirol
U.S. Highbush Blueberry Council
Organization Involved with Phase 2 Indications (189)
Access Community Health Network
Alleanza Pharmaceuticals, Inc.
Arizona Department of Health Services
Autonomous University of Madrid
Ballinasloe co Galway (Ireland)
Cardiovascular Clinical Science Foundation
Catholic University of Sacred Heart, Rome
Centro de Investigación Biomédica en Red (CIBER)
Centro de la Salud de Vistalegre - La Flota, Murcia (Spain)
Centro de Salud Murcias San Andres - Murcia (Spain)
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
Glaucoma Associates of New York
Great Lakes Drug Development, Inc.
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Handok Pharmaceuticals Co., Ltd.
Heart and Stroke Foundation of Canada
Hospital de Conxo - Santiago de Compostela
Hospital General Dr. Manuel Gea Gonzalez
Instituto Nacional de Cardiologia Ignacio Chavez
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
National Autonomous University of Mexico
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Hospital Organisation Nagoya Medical Centre
National Hospital Organization Okayama Medical Center
National Institute for Health Research, United Kingdom
National Institute of Allergy and Infectious Diseases (NIAID)
National Natural Science Foundation of China
New York Presbyterian Hospital
Office of Dietary Supplements (ODS)
Oregon Health and Science University
Philipps University of Marburg
Pontificia Universidad Catolica de Chile
Shanghai Pharmaceuticals Holding Co., Ltd
Singapore Eye Research Institute
Smerud Medical Research Denmark
The Cardiovascular Medical Research and Education Fund
The Center for Clinical Research, Winston-Salem, NC
University of Colorado, Boulder
University of Illinois at Chicago
U.O. Cardiologia - Ospedale Civile di Schio (Vicenza) Italy
Wild Blueberry Association of North America
Organization Involved with Phase 1 Indications (63)
California Institute for Regenerative Medicine
Centro Neurológico de Pesquisa e Reabiitação, Brazil
Gmax Biopharm Australia Pty Ltd.
Hospital Carlos Fernando Malzoni
Memorial Health University Medical Center
National University of Singapore
New Orleans Center for Clinical Research
North Carolina Agriculture & Technical State University
North Carolina A&T State Univeristy
Orlando Clinical Research Center
Organization Involved with Other Experimental Indications (119)
Alex Ekwueme Federal University Teaching Hospital
Alliance for Potato Research and Education
Atlanta Vascular Research Foundation
Beijing Hypertension League Insititute
Bio-Kinetic Clinical Applications
California Walnut Growers Association
Centre for Fetal Programming, Denmark
East Coast Institute for Research
Faculdade de Medicina de Botucatu
Fundación Cardioinfantil Instituto de Cardiología
Fundación Neumologica Colombiana
Hoosier Cancer Research Network
Hypertension Institute, Nashville
Illinois Institute of Technology
Institute of Experimental Endocrinology SAS
Institute of Liver and Biliary Sciences, India
Institut Hospital del Mar d'Investigacions Mèdiques
Methodist Cancer Center, Houston, Texas
National Cheng Kung University
National Research Center for Preventive Medicine
National University of Ireland
Natural and Organic Olive Oil Producer Association
Purity Life Health Products LP
Rajiv Gandhi University of Health Sciences
Shanxi Kangbao Pharmaceutical company
The Danish Council for Strategic Research
The Louis & Rachel Rudin Foundation
The S. Daniel Abraham International Center for Health and Nutrition
Top Institute Food and Nutrition
University of California, Irvine
University of Science and Technology of China
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
